Ann M. Bullion
GlaxoSmithKline (United States)(US)
Publications by Year
Research Areas
Chronic Lymphocytic Leukemia Research, Quinazolinone synthesis and applications, Computational Drug Discovery Methods, Immune Response and Inflammation, Pharmaceutical and Antibiotic Environmental Impacts
Most-Cited Works
- → Discovery and SAR of Novel 2,3‐Dihydroimidazo[1,2‐c]quinazoline PI3K Inhibitors: Identification of Copanlisib (BAY 80‐6946)(2016)113 cited
- → Development of GSK's reagent guides – embedding sustainability into reagent selection(2013)105 cited
- → 3,5-Disubstituted-indole-7-carboxamides as IKKβ Inhibitors: Optimization of Oral Activity via the C3 Substituent(2018)9 cited
- → Tyrosine urea muscarinic acetylcholine receptor antagonists: Achiral quaternary ammonium groups(2012)3 cited
- → 444 Novel 2,3-dihydroimidazo[1,2-c]quinazolines PI3K inhibitors: Discovery and SAR(2010)1 cited
- → X-ray structure of PI3Kinase Gamma in complex with Copanlisib(2016)